BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20649760)

  • 1. Double filtration plasmapheresis in antibody-incompatible kidney transplantation.
    Higgins R; Lowe D; Hathaway M; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Chen K; Krishnan N; Hamer R; Zehnder D; Briggs D
    Ther Apher Dial; 2010 Aug; 14(4):392-9. PubMed ID: 20649760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience of ABO-incompatible living kidney transplantation after double filtration plasmapheresis.
    Ishikawa A; Itoh M; Ushlyama T; Suzuki K; Fujita K
    Clin Transplant; 1998 Apr; 12(2):80-3. PubMed ID: 9575393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-filtration plasmapheresis.
    Tanabe K
    Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ABO incompatible living donor kidney transplantation: a dream come true. Experience of Hospital Clínic of Barcelona].
    Oppenheimer F; Revuelta I; Serra N; Lozano M; Gutiérrez-Dalmau A; Esforzado N; Cofán F; Ricart MJ; Torregrosa JV; Crespo M; Paredes D; Martorell J; Alcáraz A; Campistol JM
    Nefrologia; 2010; 30(1):54-63. PubMed ID: 20038970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
    Han S; Hwang E; Park S; Park U; Kim H; Cho W
    Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of theefficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis.
    Kobayashi T; Yokoyama I; Morozumi K; Nagasaka T; Hayashi S; Uchida K; Takagi H; Nakao A
    Xenotransplantation; 2000 May; 7(2):101-8. PubMed ID: 10961294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult ABO-incompatible liver transplantation, using A and B donors.
    Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L
    Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience.
    Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P
    Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present status of ABO-incompatible kidney transplantation in Japan.
    Takahashi K; Saito K
    Xenotransplantation; 2006 Mar; 13(2):118-22. PubMed ID: 16623804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
    Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO-incompatible renal transplantation at Tokyo Women's Medical University.
    Tanabe K; Tokumoto T; Ishida H; Toma H; Nakajima I; Fuchinoue S; Teraoka S
    Clin Transpl; 2003; ():175-81. PubMed ID: 15387109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
    Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
    Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center.
    Naciri Bennani H; Noble J; Chevallier E; Terrec F; Motte L; Giroux-Lathuile C; Bugnazet M; Imerzoukene F; Janbon B; Malvezzi P; Rostaing L; Jouve T
    J Clin Apher; 2021 Feb; 36(1):149-160. PubMed ID: 33230824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of renal transplantation from an ABO-incompatible donor successfully pretreated with double filtration plasmapheresis].
    Hirano Y; Ohira T; Ishikawa A; Ushiyama T; Suzuki K; Fujita K
    Hinyokika Kiyo; 1996 Nov; 42(11):887-90. PubMed ID: 8973941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization by blood-type antigen in human immunoglobulin products before ABO-incompatible kidney transplantation.
    Sawada T; Ando T; Sato S; Kubota K; Fuchinoue S; Teraoka S
    Clin Transplant; 2004 Apr; 18(2):219-21. PubMed ID: 15016140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy and DFPP-enabled non-responders to undergo ABO-incompatible kidney transplantation.
    Sawada T; Fuchinoue S; Kawase T; Kubota K; Teraoka S
    Clin Transplant; 2004 Jun; 18(3):254-60. PubMed ID: 15142045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients.
    Otsubo S; Tanabe K; Shinmura H; Ishikawa N; Tokumoto T; Hattori M; Ito K; Nitta K; Akiba T; Nihei H; Toma H
    Ther Apher Dial; 2004 Aug; 8(4):299-304. PubMed ID: 15274681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation.
    Ushigome H; Okamoto M; Koshino K; Nobori S; Okajima H; Masuzawa N; Urasaki K; Yoshimura N
    Clin Transplant; 2010 Jul; 24 Suppl 22():16-21. PubMed ID: 20590688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.